| JYHB1000342 | 注射用替卡西林钠克拉维酸钾 | potassium clavulanate;ticarcillin sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2010-05-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Beecham Group Plc;Smithkline Beecham Plc | Certificate Issued | 2010-08-31 | view |
| JYHB1800247 | 多替拉韦钠片 | | Tablet | Chemical Drugs | Supplementary Application | 2018-03-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Viiv Healthcare Uk Ltd | Certificate Issued | 2019-07-01 | view |
| JYHZ1900157 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2019-07-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2019-11-25 | view |
| JYHB2001496 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-08-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | Filed | 2020-08-31 | view |
| JYHB1301519 | 注射用阿莫西林钠克拉维酸钾 | amoxicillin sodium;potassium clavulanate | Lyophilized | Chemical Drugs | Supplementary Application | 2013-12-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd;Beecham Group Plc | Certificate Issued | 2014-06-19 | view |
| JYHB1401331 | 硫酸阿巴卡韦口服溶液 | abacavir sulfate | Oral solution | Chemical Drugs | Supplementary Application | 2014-10-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare Uk Ltd;Glaxosmithkline Inc | Certificate Issued | 2015-06-19 | view |
| H20020081 | 阿莫西林/克拉维酸钾干混悬剂 | amoxicillin;potassium clavulanate | Suspension | Chemical Drugs | Import Drug Application | 2002-04-09 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| JYHZ2000284 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Inc;Patheon Inc | In Review | 2022-01-20 | view |
| JXHL0900284 | 吸入用硫酸沙丁胺醇溶液 | salbutamol sulfate | Inhalation | Chemical Drugs | Import Drug Application | 2009-09-04 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd | Certificate Issued | 2010-04-23 | view |
| JYHB1701457 | 阿莫西林克拉维酸钾片 | amoxicillin;potassium clavulanate | Tablet | Chemical Drugs | Supplementary Application | 2017-11-17 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Smithkline Beecham Ltd;Beecham Group Plc | Filed | 2017-12-10 | view |
| JYHZ1800443 | 度他雄胺软胶囊 | dutasteride | Soft capsules | Chemical Drugs | License Renew | 2019-01-02 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Phaemaceuticals SA;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2019-06-19 | view |
| JYHB0700934 | 沙美特罗替卡松粉吸入剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2007-09-12 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome Operations | Certificate Issued | 2008-05-27 | view |
| JYSB1300216 | 流感病毒裂解疫苗 | influenza vaccine(split virion),inactivated | Injection | Biological Products | Supplementary Application | 2013-09-06 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxosmithkline Biologicals Branch Of Smithkline Beecham Pharma Gmbh & Co KG | Certificate Issued | 2014-08-11 | view |
| JYHB1400675 | 注射用头孢呋辛钠 | cefuroxime sodium | Lyophilized | Chemical Drugs | Supplementary Application | 2014-06-11 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Manufacturing SpA;GlaxoSmithKjine SpA | Certificate Issued | 2014-12-24 | view |
| JXHL1200137 | 瑞替加滨片 | retigabine | Tablet | Chemical Drugs | Import Drug Application | 2012-05-14 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd | Certificate Issued | 2013-06-25 | view |
| JYHB2001175 | 盐酸伐昔洛韦片 | valaciclovir hydrochloride | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-07-24 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;Glaxo Wellcome SA | Filed | 2020-07-31 | view |
| JYHB2002510 | 拉米夫定片 | lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2020-12-07 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV;GlaxoSmithKline Phaemaceuticals SA | Filed | 2020-12-16 | view |
| JYHB2100178 | 拉西地平片 | lacidipine | Tablet | Chemical Drugs | Supplementary Application | 2021-03-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-03-05 | view |
| JYHB1501771 | 沙美特罗替卡松粉吸入剂 | fluticasone propionate;salmeterol xinafoate | Inhalation | Chemical Drugs | Supplementary Application | 2015-12-17 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2018-08-14 | view |
| JYHB1700953 | 注射用头孢他啶 | ceftazidime | Lyophilized | Chemical Drugs | Supplementary Application | 2017-07-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Manufacturing SpA;GlaxoSmithKjine SpA | Filed | 2017-08-14 | view |
